Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04979117
Other study ID # ES01
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 28, 2021
Est. completion date December 27, 2022

Study information

Verified date December 2022
Source Nigde Omer Halisdemir University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

A prospective study will be conducted to evaluate the diagnostic performance of SMI, gray scale US, color Doppler US and Power Doppler US.


Description:

Plantar fasciitis (PF) is a painful condition of the inferior and medial heel. Symptoms worsens with the first steps in the morning or after prolonged sitting and long periods of standing. The diagnosis of PF is made according to the typical anamnesis and physical examination, based on the emerge of local point tenderness over the heel and proximal fascia due to the pressure applied by the physician. Heel pain exacerbates by the first steps in the morning or after rest and with prolonged standing. Unless there is an inflammatory disease such as spondyloarthropathy, there is no laboratory finding indicating plantar fasciitis. Imaging methods are very useful for making an accurate diagnosis. Because the main problem is in the soft tissue, plain radiography has limited diagnostic value, but can be helpful in identifying calcaneal stress fractures. Magnetic resonance imaging (MRI) is very successful in showing the inflammatory process of soft tissue. However, it does not seem possible to use MRI scans routinely because of the cost and time it requires. PF can be evaluated with ultrasonography with the advantages of being non-invasive, relatively inexpensive, easy to access and apply, and is increasingly used in clinical practice. Color Doppler evaluation is a very valuable part of musculoskeletal sonographic examination and facilitates the clinician's decision as an inflammation marker. Power Doppler US is quite sensitive to tissue or probe movement, especially at low pulsed repetition frequency (PRF). Flash artifacts may be observed. However, Doppler USG has limited sensitivity at low flows and small vessel structures. Superb microvascular imaging (SMI) (Toshiba Medical Systems, Tokyo, Japan) is a new mode of vascular imaging that provides visualization of activity in microvascular structures or in structures that have low flow rate. To the best of our knowledge, there are no studies comparing the diagnostic performance of the SMI modality in plantar fasciitis with color Doppler and gray scale US. Therefore, a prospective study will be conducted to evaluate the diagnostic performance of SMI, gray scale US, color Doppler US and Power Doppler US. The null hypothesis that there is no difference between Doppler US and SMI methods in the detection of increased inflammatory activity in plantar fasciitis patients.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date December 27, 2022
Est. primary completion date December 27, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 45 Years
Eligibility For the first group: Inclusion Criteria: - Patients who diagnosed as Plantar Fasciitis - Age between 18-45 Exclusion Criteria: - History of foot trauma or surgery - Diabetes mellitus - Pregnancy, - Rheumatological diseases For the second group: Inclusion Criteria: - asymptomatic foot, - no previous trauma or surgery on foot, - no history of systemic inflammatory disorders. Exclusion Criteria: - History of foot trauma or surgery - Diabetes mellitus - Pregnancy, - Rheumatological diseases

Study Design


Intervention

Device:
Superb Microvascular Imaging (SMI) (Toshiba)
to determine whether there is a diagnostic value of SMI in Plantar Fasciitis and whether there is a superiority when compared Power Doppler and Color Doppler modalities.

Locations

Country Name City State
Turkey Nigde Omer Halisdemir University Nigde

Sponsors (1)

Lead Sponsor Collaborator
Nigde Omer Halisdemir University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visual Analog Scale (VAS) Pain Score The patient will be asked to indicate his/her perceived pain intensity (most commonly) along a 100 mm horizontal line. This rating is then measured from the left edge gives the VAS score. A higher score indicates greater pain intensity and lower scores indicates less pain intensity. Each participant will be assessed only one time at the admission time to the outpatient clinic
Primary Heel Tenderness Index (HTI) Heel tenderness index (HTI) will be assessed by physician; based on assessing pain on palpation (0=no pain, 1=painful, 2=painful and winces, 3=painful, winces and withdraws). Each participant will be assessed only one time at the admission time to the outpatient clinic
Primary Foot Function Index (FFI) This index aims to measure the impact of foot pathology on function in terms of pain, disability and activity restriction. The FFI is a self-administered index consisting of 23 items divided into 3 sub-scales. Each participant will be assessed only one time at the admission time to the outpatient clinic
Primary Ultrasonographic Evaluation; Superb Microvascular Imaging, GrayScale Imaging, Color Doppler Imaging, Power Doppler Imaging Vascular blood flow images from median nerve (enterrapted in carpal tunnel) obtained with Power Doppler and Superb microvascular imaging. [ Time Frame: Each participant will be assessed only one time at the admission time to the outpatient clinic ] Four-stage classify will be use for grading these images; Grade 0: No vascularity in MN, Grade 1: One or two focal color-encoded spots in MN, Grade 2: One linear color-encoded line or more than two focal color-encoded spots in MN, Grade 3: More than one linear color-encoded line in MN Each participant will be assessed only one time at the admission time to the outpatient clinic
See also
  Status Clinical Trial Phase
Completed NCT02546115 - RCT - Assessing the Benefits of the Use of a Tension Night Splint in Patients With Plantar Fasciitis N/A
Terminated NCT01996111 - Dehydrated Human Amnion/Chorion Membrane Micrografts(dHACM) Injectable in the Treatment of Recalcitrant Plantar Fasciitis N/A
Unknown status NCT01882894 - Efficacy of a Custom Temporary Foot Orthosis for Plantar Fasciitis Treatment N/A
Completed NCT01659827 - Comparative Study of Amniotic Membrane Injectable in the Treatment of Recalcitrant Plantar Fasciitis N/A
Completed NCT00888394 - Effectiveness of Podiatry on Plantar Pain Phase 4
Completed NCT00758641 - Platelet Rich Plasma to Treat Plantar Fasciitis Phase 4
Terminated NCT00527748 - Foot and Ankle Range of Motion (Stretching) Apparatus N/A
Recruiting NCT05584046 - A Single-blind RCT to Investigate the Effect of a Novel Herbal Patch for the Treatment of PF N/A
Completed NCT04088383 - Amnios™ RT Outcomes Study N/A
Completed NCT01994759 - Optimal Treatment of Plantar Fasciitis: Physical Training, Glucocorticoid Injections or a Combination Thereof. Phase 4
Completed NCT02646579 - Effects of Dry Needling Using Spinal and Peripheral Sites Versus Peripheral Sites Only N/A
Completed NCT05592808 - Comparison of Taping Techniques in Plantar Fasciitis N/A
Not yet recruiting NCT04125264 - Intense Therapeutic Ultrasound (ITU) to Treat Plantar Fasciitis N/A
Completed NCT02546089 - ABI v Dry Needling for Plantar Fasciitis N/A
Completed NCT00765843 - A Trial of Custom Foot Orthoses for the Treatment of Plantar Heel Pain N/A
Completed NCT00155324 - Change and Clinical Significance of Plantar Fascia Thickness After ESWT N/A
Completed NCT04941469 - Effectiveness of Specifically Optimized Off-the-counter Foot Orthosis for the Subtle Cavus Foot N/A
Completed NCT06055933 - Effect of Kinesio Taping and Extracorporeal Shock Wave Therapy on Plantar Fasciitis
Recruiting NCT02539082 - the Safety and Efficacy of Collagen Injection in Patients With Plantar Fasciitis Phase 4
Enrolling by invitation NCT01786057 - Effect of Extracorporeal Shock Wave Therapy of Gastrosoleus Trigger Points in Patients With Plantar Fasciitis Phase 2/Phase 3